ACEA Biosciences, Inc. Announces New Patent
Broad Claims Granted for Cytotoxicity Profiling and Chemical Compound Testing
18-Feb-2011 -
ACEA Biosciences, Inc. reported the issuance of a new U. S. Patent for chemical compound screening, with important applications in the development of new pharmaceutical products. Testing and profiling of these candidate compounds by means of ACEA's real-time, label-free microelectronic technology ...
cytotoxicity
cytotoxicity assays
Roche Diagnostics